lobbying_activities: 2113501

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2113501	9d3cbd2f-ac68-4711-8062-f50aa98e2072	Q1	BROWN RUDNICK LLP	287895	HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC	2018	first_quarter	PHA	Public Law 113-54-Drug Quality and Security Act; S.469-The Affordable and Safe Prescription Drug Importation Act; H.R. 5267 relating to DEA controlled substances registration; Public Law 114-145-The Ensuring Patient Access and Effective Drug Enforcement Act; Issues relating to prescription drug abuse and diversion.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2018-04-19T10:29:00.680000-04:00